Profile | GDS5420 / 235430_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 998.74 | 79 |
GSM1296119 | B_lesional_pre-dose | 335.02 | 61 |
GSM1296076 | C_lesional_pre-dose | 154.24 | 50 |
GSM1296092 | D_lesional_pre-dose | 180.06 | 52 |
GSM1296103 | E_lesional_pre-dose | 774.59 | 75 |
GSM1296078 | F_lesional_pre-dose | 161.61 | 51 |
GSM1296107 | G_lesional_pre-dose | 463.7 | 66 |
GSM1296109 | H_lesional_pre-dose | 601.83 | 70 |
GSM1296080 | I_lesional_pre-dose | 392.57 | 64 |
GSM1296090 | J_lesional_pre-dose | 174.24 | 51 |
GSM1296074 | K_lesional_pre-dose | 141.56 | 49 |
GSM1296111 | L_lesional_pre-dose | 299.99 | 59 |
GSM1296099 | M_lesional_pre-dose | 569.39 | 70 |
GSM1296086 | O_lesional_pre-dose | 188.5 | 53 |
GSM1296117 | P_lesional_pre-dose | 311.73 | 59 |
GSM1296113 | Q_lesional_pre-dose | 350.84 | 61 |
GSM1296096 | R_lesional_pre-dose | 619.94 | 71 |
GSM1296105 | S_lesional_pre-dose | 707.87 | 73 |
GSM1296098 | T_lesional_pre-dose | 1005 | 79 |
GSM1296101 | U_lesional_pre-dose | 787.64 | 75 |
GSM1296121 | V_lesional_pre-dose | 425.49 | 65 |
GSM1296088 | W_lesional_pre-dose | 245.46 | 56 |
GSM1296082 | X_lesional_pre-dose | 167.97 | 51 |
GSM1296115 | Y_lesional_pre-dose | 376.89 | 63 |
GSM1296084 | Z_lesional_pre-dose | 247.99 | 56 |
GSM1296072 | B_lesional_day8 | 298 | 58 |
GSM1296069 | L_lesional_day8 | 361.52 | 61 |
GSM1296071 | P_lesional_day8 | 375.65 | 62 |
GSM1296070 | Y_lesional_day8 | 291.25 | 58 |
GSM1296073 | V_lesional_day8 | 327.61 | 61 |
GSM1296034 | A_lesional_day15 | 1341.77 | 84 |
GSM1296041 | G_lesional_day15 | 284.57 | 58 |
GSM1296035 | R_lesional_day15 | 604.23 | 71 |
GSM1296038 | U_lesional_day15 | 510.22 | 68 |
GSM1296047 | B_lesional_day15 | 373.35 | 62 |
GSM1296039 | E_lesional_day15 | 254.8 | 57 |
GSM1296042 | H_lesional_day15 | 267.64 | 56 |
GSM1296043 | L_lesional_day15 | 407.55 | 64 |
GSM1296037 | M_lesional_day15 | 647.94 | 72 |
GSM1296046 | P_lesional_day15 | 372.94 | 62 |
GSM1296044 | Q_lesional_day15 | 421.58 | 64 |
GSM1296045 | Y_lesional_day15 | 335.93 | 60 |
GSM1296025 | C_lesional_day15 | 456.13 | 66 |
GSM1296033 | D_lesional_day15 | 192.3 | 52 |
GSM1296027 | I_lesional_day15 | 88.05 | 42 |
GSM1296032 | J_lesional_day15 | 246.64 | 55 |
GSM1296024 | K_lesional_day15 | 443.56 | 66 |
GSM1296031 | W_lesional_day15 | 369.23 | 62 |
GSM1296028 | X_lesional_day15 | 229.73 | 55 |
GSM1296029 | Z_lesional_day15 | 328.14 | 60 |
GSM1296026 | F_lesional_day15 | 249.43 | 57 |
GSM1296030 | O_lesional_day15 | 106.21 | 45 |
GSM1296040 | S_lesional_day15 | 1056.64 | 80 |
GSM1296036 | T_lesional_day15 | 845.91 | 76 |
GSM1296048 | V_lesional_day15 | 354.9 | 62 |
GSM1296059 | A_lesional_day43 | 695.45 | 73 |
GSM1296066 | G_lesional_day43 | 377.87 | 63 |
GSM1296060 | R_lesional_day43 | 543.51 | 69 |
GSM1296063 | U_lesional_day43 | 279.15 | 58 |
GSM1296064 | E_lesional_day43 | 311.84 | 60 |
GSM1296067 | H_lesional_day43 | 391 | 62 |
GSM1296062 | M_lesional_day43 | 727.16 | 74 |
GSM1296068 | Q_lesional_day43 | 331.87 | 59 |
GSM1296050 | C_lesional_day43 | 242.12 | 56 |
GSM1296057 | D_lesional_day43 | 636.79 | 71 |
GSM1296052 | I_lesional_day43 | 107.22 | 44 |
GSM1296054 | J_lesional_day43 | 329.97 | 60 |
GSM1296049 | K_lesional_day43 | 274.22 | 58 |
GSM1296055 | W_lesional_day43 | 690.46 | 73 |
GSM1296053 | X_lesional_day43 | 295.17 | 58 |
GSM1296058 | Z_lesional_day43 | 417.3 | 65 |
GSM1296051 | F_lesional_day43 | 185.26 | 52 |
GSM1296056 | O_lesional_day43 | 421.28 | 65 |
GSM1296065 | S_lesional_day43 | 396.4 | 64 |
GSM1296061 | T_lesional_day43 | 972.34 | 79 |
GSM1296095 | A_non-lesional_pre-dose | 624.04 | 72 |
GSM1296120 | B_non-lesional_pre-dose | 419.32 | 64 |
GSM1296077 | C_non-lesional_pre-dose | 437.72 | 66 |
GSM1296093 | D_non-lesional_pre-dose | 516.28 | 68 |
GSM1296104 | E_non-lesional_pre-dose | 615.11 | 71 |
GSM1296079 | F_non-lesional_pre-dose | 324.63 | 61 |
GSM1296108 | G_non-lesional_pre-dose | 492.93 | 67 |
GSM1296110 | H_non-lesional_pre-dose | 552.31 | 69 |
GSM1296081 | I_non-lesional_pre-dose | 507.57 | 68 |
GSM1296091 | J_non-lesional_pre-dose | 203.39 | 53 |
GSM1296075 | K_non-lesional_pre-dose | 206.97 | 54 |
GSM1296112 | L_non-lesional_pre-dose | 461.78 | 66 |
GSM1296100 | M_non-lesional_pre-dose | 1010.14 | 79 |
GSM1296087 | O_non-lesional_pre-dose | 70.98 | 39 |
GSM1296118 | P_non-lesional_pre-dose | 509.63 | 68 |
GSM1296114 | Q_non-lesional_pre-dose | 402.83 | 63 |
GSM1296097 | R_non-lesional_pre-dose | 544.38 | 69 |
GSM1296106 | S_non-lesional_pre-dose | 729.39 | 74 |
GSM1296102 | U_non-lesional_pre-dose | 740.57 | 74 |
GSM1296122 | V_non-lesional_pre-dose | 337.67 | 61 |
GSM1296089 | W_non-lesional_pre-dose | 363.34 | 62 |
GSM1296083 | X_non-lesional_pre-dose | 773.35 | 75 |
GSM1296116 | Y_non-lesional_pre-dose | 456.6 | 65 |
GSM1296085 | Z_non-lesional_pre-dose | 157.02 | 48 |